Hunan Nucien Pharmaceutical Co., Ltd. (SHA:688189)

SHA:688189 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	347.18	301.52	490.27	665.76	713.47	730.67
Cash & Short-Term Investments	347.18	301.52	490.27	665.76	713.47	730.67
Cash Growth	-20.98%	-38.50%	-26.36%	-6.69%	-2.35%	-24.04%
Accounts Receivable	21.65	42.51	199.9	563.74	741.49	590.81
Other Receivables	27.56	8.34	5.78	0.95	6.36	220.08
Receivables	49.21	50.85	205.68	564.69	747.85	810.9
Inventory	34.35	35.88	61.17	30.37	27.01	61.43
Prepaid Expenses	-	-	1.62	3.52	0.32	-
Other Current Assets	11.29	11.58	19.61	7.52	7.51	10.19
Total Current Assets	442.03	399.83	778.35	1,272	1,496	1,613
Property, Plant & Equipment	142.63	150.08	164.3	186.29	204.62	229.74
Goodwill	-	-	-	10.85	10.85	13.57
Other Intangible Assets	83.86	88.87	143.13	124.28	138.01	158.41
Long-Term Deferred Tax Assets	34.2	33.74	51.17	57.26	54.82	72.22
Long-Term Deferred Charges	133.16	118.42	77.5	64.19	46.23	40.48
Other Long-Term Assets	18.53	18.53	7.99	4.65	3.91	3.27
Total Assets	854.41	809.47	1,222	1,719	1,955	2,131

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	23.89	27.23	39.59	39.55	37.5	156.47
Accrued Expenses	31.47	26.22	53.39	31.97	39.26	52.77
Short-Term Debt	60.02	10.03	218.19	322.95	488.73	385.44
Current Portion of Long-Term Debt	-	-	-	-	50.85	33.9
Current Portion of Leases	-	-	0.71	0.71	0.68	1.13
Current Income Taxes Payable	0.57	0.57	0.57	1.2	2	-
Current Unearned Revenue	6.23	1.96	1.72	13.48	13.3	27.21
Other Current Liabilities	19.03	27.52	25.69	18.17	16.04	17.76
Total Current Liabilities	141.21	93.52	339.85	428.04	648.36	674.67
Long-Term Debt	-	-	-	-	-	50.85
Long-Term Leases	-	-	0.23	0.94	3.39	4.07
Long-Term Unearned Revenue	2.55	2.7	3	3.3	4.2	5.62
Long-Term Deferred Tax Liabilities	0.74	0.84	1.05	1.53	2.29	1.68
Total Liabilities	144.5	97.06	344.13	433.8	658.24	736.89

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	274.4	274.4	274.4	274.4	196	140
Additional Paid-In Capital	1,213	1,175	1,175	1,175	1,254	1,310
Retained Earnings	-677.29	-640.12	-503.22	-146.32	-135.45	-56.62
Treasury Stock	-30	-26.14	-10	-	-	-
Total Common Equity	780.52	783.55	936.59	1,303	1,314	1,393
Minority Interest	-70.61	-71.14	-58.29	-17.92	-17.99	0.79
Shareholders' Equity	709.91	712.41	878.31	1,286	1,296	1,394
Total Liabilities & Equity	854.41	809.47	1,222	1,719	1,955	2,131

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	60.02	10.03	219.12	324.6	543.65	475.38
Net Cash (Debt)	287.16	291.49	271.15	341.16	169.82	255.29
Net Cash Growth	-1.40%	7.50%	-20.52%	100.89%	-33.48%	-58.59%
Net Cash Per Share	1.05	1.06	0.99	1.24	0.62	0.93
Filing Date Shares Outstanding	270.44	272.49	272.83	274.4	274.4	274.4
Total Common Shares Outstanding	270.44	272.49	272.83	274.4	274.4	274.4
Working Capital	300.82	306.31	438.5	843.82	847.82	938.51
Book Value Per Share	2.89	2.88	3.43	4.75	4.79	5.08
Tangible Book Value	696.66	694.68	793.46	1,168	1,166	1,221
Tangible Book Value Per Share	2.58	2.55	2.91	4.26	4.25	4.45
Buildings	220.68	220.68	220.56	220.56	220.27	220.27
Machinery	200.61	198.2	229.88	270.67	264.88	262.76
Construction In Progress	4.9	4.9	0.35	0.57	0.24	1.28

Data Source: S&P Global Market Intelligence Last updated: Aug 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 6, 2026

Data Sources Report a data error